References
- 1. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WM, et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012; 33(13): 1635-1701.
- 2. National Heart Lung and Blood Institute (http:// www.nhlbi.nih.gov/health/health-topics/topics/atherosclerosis/) (accessed 3 April 2013).
- 3. Kristenson M, Olsson AG, Kucinskiene Z. Good self-rated health is related to psychosocial resources and a strong cortisol response to acute stress: the LiVicordia study of middle-aged men. Int J Behav Med. 2005; 12(3): 153-160.
- 4. Pepalyte I, Kucinskiene Z, Grigalionienė K, Petrulionienė Z, Dzenkeviciute V, Bagdonaite L, et al. Genetic variants that participate in oxidation processes and/or oxidative stress and are associated with atherosclerosis. Eur Med Health Pharmaceut J. 2012; 3: 13-16.
- 5. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gonzalez-Sanchez JL, Seclen S, Villena A, et al. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care. 2006; 29(3): 685-691.
- 6. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet. 2007; 81(3): 559-575.
- 7. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (iddm). Am J Hum Genet. 1993; 52(3): 506-516.
- 8. Germanas Š, Jakaitiene A. Power approximation of the transmission disequilibrium test. Lithuanian Mathemat J. 2012; Series B, 53(Series B): 56-61 (in Lithuanian)
- 9. National Center for Biotechnology Information (NCBI) Gene database (http://www.ncbi.nlm.nih.gov/gene/57142( (accessed 3 April 2013).
- 10. Whitley E, Ball J. Statistics review 4: sample size calculations. Crit Care. 2002; 6(4): 335-341.
- 11. Barrett J, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, et al. A genome-wide association study and metaanalysis indicate that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009; 41(6): 703-707.
- 12. Chen Y, Zhao S, Xiang R. RTN3 and RTN4: candidate modulators in vascular cell apoptosis and atherosclerosis. J Cell Biochem. 2010; 111(4): 797-800.
- 13. Jitoku D, Hattori E, Iwayama Y, Yamada K, Toyota T, Kikuchi M, et al. Association study of Nogo-related genes with schizophrenia in a Japanese case-control sample. Am J Med Genet B Neuropsychiatr Genet. 2011; 156B(5): 581-592.
- 14. Kathiresan S, Manning AK, Demissie S, D’Agostino RB, Surti A, Guiducci C, et al. A genomewide association study for blood lipid phenotypes in the Fram-ingham Heart Study. BMC Med Genet. 2007; 8(Suppl 1): S17.
- 15. Acevedo L, Yu J, Erdjument-Bromage H, Miao RQ, Kim JE, Fulton D, et al. A new role for Nogo as a regulator of vascular remodelling. Nat Med. 2004; 10(4): 382-388.
- 16. Rodriguez-Feo JA, Hellings WE, Verhoeven BAN, Moll FL, de Kleijn DPV, Prendergast J, et al. Low levels of Nogo-B in human carotid atherosclerotic plaques are associated with an atheromatous phenotype, restenosis, and stenosis severity. Arterioscler Thromb Vasc Biol. 2007; 27: 1354-1360.
- 17. Harrison KD, Miao RQ, Fernandez-Hernándo C, Suárez Y, Dávalos A, Sessa WC. Nogo-B receptor stabilizes Niemann-Pick type C2 protein and regulates intra-cellular cholesterol trafficking. Cell Metab. 2009; 10(3): 208-218.
- 18. Jin J, Cardozo T, Lovering RC, Elledge SJ, Pagano M, Harper JW. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 2004; 18(21): 2573-2580.
- 19. Depre C, Powell SR, Wang X. The role of the ubiquitin-proteasome pathway in cardiovascular disease. Cardiovasc Res. 2010; 85(2): 251-252.